10-Nov-2025 3:01 PM CST - Business Wire Quanterix Releases Financial Results for the Third Quarter of 2025 Quanterix Corporation (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced financial results for the third quarter ended September 30, 2025. During the third quarter, we delivered on our revenue expectations despite challenging market conditions, said Masoud Toloue, Chief Executive Officer of Quanterix. Equally important, we achieved key integration milestones from our Akoya
3-Nov-2025 6:00 AM CST - Business Wire Quanterix To Report Third Quarter 2025 Financial Results on November 10, 2025 Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it will host a conference call on Monday, November 10, 2025, at 4:30 p.m. E.T., to discuss its third quarter 2025 financial results. Quanterix will issue a press release regarding its third quarter 2025 financial results prior to the conference call on Monday, November 10, 2025, after the market closes. The press release
11-Aug-2025 6:00 AM CST - Business Wire Quanterix to Present at the Canaccord Genuity 45th Annual Growth Conference Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that its executive leadership team will present at the Canaccord Genuity 45th Annual Growth Conference in Boston, Massachusetts on Tuesday, August 12th, at 3:30 p.m. ET. Quanterix will also host one-on-one meetings with institutional investors during the conference. Webcast Information The live webcast presentation can be acc
7-Aug-2025 3:06 PM CST - Business Wire Quanterix Releases Financial Results for the Second Quarter of 2025 Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announced financial results for the second quarter ended June 30, 2025. Through our combination with Akoya Biosciences, we have created a high-margin, high-throughput business with a compelling opportunity to deliver profitable growth in an expanded market, said Masoud Toloue, CEO of Quanterix. We have built a franchise that is gen
4-Aug-2025 3:02 PM CST - Business Wire Quanterix To Report Second Quarter 2025 Financial Results on August 7, 2025 Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it will host a conference call on Thursday, August 7, 2025, at 4:30 p.m. E.T., to discuss its second quarter 2025 financial results. Quanterix will issue a press release regarding its second quarter 2025 financial results prior to the conference call on Thursday, August 7, 2025, after the market closes. The press release
6-Jun-2025 8:41 AM CST - Business Wire Quanterix to Present at Goldman Sachs Global Healthcare Conference Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that President and Chief Executive Officer Masoud Toloue will present at the Goldman Sachs 46th Annual Global Healthcare Conference in Miami, Florida on Monday, June 9th, at 1:20 p.m. ET. Quanterix will also host one-on-one meetings with institutional investors during the conference. Webcast Information The live webcast prese
12-May-2025 3:01 PM CST - Business Wire Quanterix Releases Financial Results for the First Quarter of 2025 Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announced financial results for the first quarter ended March 31, 2025. "During a time when market resource constraints threaten to slow scientific progress, we remain committed to keeping the innovation engine moving forward, said Masoud Toloue, CEO of Quanterix. "Today, we are excited to announce a major advance: through a new earl
5-May-2025 6:00 AM CST - Business Wire Quanterix To Report First Quarter 2025 Financial Results on May 12, 2025 Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it will host a conference call on Monday, May 12, 2025, at 4:30 p.m. E.T., to discuss its first quarter 2025 financial results. Quanterix will issue a press release regarding its first quarter 2025 financial results prior to the conference call on Monday, May 12, 2025, after the market closes. The press release will be p
17-Mar-2025 3:01 PM CST - Business Wire Quanterix Releases Financial Results for the Fourth Quarter of 2024 Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announced financial results for the fourth quarter ended December 31, 2024. During the fourth quarter, we delivered 11% revenue growth, our seventh straight quarter of double-digit growth, despite a capital constrained environment, said Masoud Toloue, Chief Executive Officer of Quanterix. Our ability to grow in a difficult environm
10-Nov-2025 3:01 PM CST - Business Wire Quanterix Releases Financial Results for the Third Quarter of 2025 Quanterix Corporation (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced financial results for the third quarter ended September 30, 2025. During the third quarter, we delivered on our revenue expectations despite challenging market conditions, said Masoud Toloue, Chief Executive Officer of Quanterix. Equally important, we achieved key integration milestones from our Akoya
3-Nov-2025 6:00 AM CST - Business Wire Quanterix To Report Third Quarter 2025 Financial Results on November 10, 2025 Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it will host a conference call on Monday, November 10, 2025, at 4:30 p.m. E.T., to discuss its third quarter 2025 financial results. Quanterix will issue a press release regarding its third quarter 2025 financial results prior to the conference call on Monday, November 10, 2025, after the market closes. The press release
11-Aug-2025 6:00 AM CST - Business Wire Quanterix to Present at the Canaccord Genuity 45th Annual Growth Conference Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that its executive leadership team will present at the Canaccord Genuity 45th Annual Growth Conference in Boston, Massachusetts on Tuesday, August 12th, at 3:30 p.m. ET. Quanterix will also host one-on-one meetings with institutional investors during the conference. Webcast Information The live webcast presentation can be acc
7-Aug-2025 3:06 PM CST - Business Wire Quanterix Releases Financial Results for the Second Quarter of 2025 Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announced financial results for the second quarter ended June 30, 2025. Through our combination with Akoya Biosciences, we have created a high-margin, high-throughput business with a compelling opportunity to deliver profitable growth in an expanded market, said Masoud Toloue, CEO of Quanterix. We have built a franchise that is gen
4-Aug-2025 3:02 PM CST - Business Wire Quanterix To Report Second Quarter 2025 Financial Results on August 7, 2025 Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it will host a conference call on Thursday, August 7, 2025, at 4:30 p.m. E.T., to discuss its second quarter 2025 financial results. Quanterix will issue a press release regarding its second quarter 2025 financial results prior to the conference call on Thursday, August 7, 2025, after the market closes. The press release
6-Jun-2025 8:41 AM CST - Business Wire Quanterix to Present at Goldman Sachs Global Healthcare Conference Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that President and Chief Executive Officer Masoud Toloue will present at the Goldman Sachs 46th Annual Global Healthcare Conference in Miami, Florida on Monday, June 9th, at 1:20 p.m. ET. Quanterix will also host one-on-one meetings with institutional investors during the conference. Webcast Information The live webcast prese
12-May-2025 3:01 PM CST - Business Wire Quanterix Releases Financial Results for the First Quarter of 2025 Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announced financial results for the first quarter ended March 31, 2025. "During a time when market resource constraints threaten to slow scientific progress, we remain committed to keeping the innovation engine moving forward, said Masoud Toloue, CEO of Quanterix. "Today, we are excited to announce a major advance: through a new earl
5-May-2025 6:00 AM CST - Business Wire Quanterix To Report First Quarter 2025 Financial Results on May 12, 2025 Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it will host a conference call on Monday, May 12, 2025, at 4:30 p.m. E.T., to discuss its first quarter 2025 financial results. Quanterix will issue a press release regarding its first quarter 2025 financial results prior to the conference call on Monday, May 12, 2025, after the market closes. The press release will be p
17-Mar-2025 3:01 PM CST - Business Wire Quanterix Releases Financial Results for the Fourth Quarter of 2024 Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announced financial results for the fourth quarter ended December 31, 2024. During the fourth quarter, we delivered 11% revenue growth, our seventh straight quarter of double-digit growth, despite a capital constrained environment, said Masoud Toloue, Chief Executive Officer of Quanterix. Our ability to grow in a difficult environm
